Impact of direct-acting oral anticoagulants and warfarin on postendoscopic GI bleeding and thromboembolic events

Post written by Andy Tien, MD, MS, from the Department of Internal Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. The focus of our study was to compare the risk of GI bleeding (GIB) and thromboembolic events among patients undergoing GI endoscopic procedures who are prescribed direct-acting oral anticoagulants (DOACs) versus warfarin. Endoscopists …

Continue reading Impact of direct-acting oral anticoagulants and warfarin on postendoscopic GI bleeding and thromboembolic events